Woolcock Institute Of Medical Research
Clinical trials sponsored by Woolcock Institute Of Medical Research, explained in plain language.
-
Sleep pill may shield brain from Alzheimer's damage
Disease control Recruiting nowThis study tests whether the insomnia medication lemborexant (Dayvigo) can lower blood markers of brain damage in adults aged 40–65 with insomnia. Twenty participants will take the drug or a placebo for two weeks each, then have their blood tested for proteins linked to Alzheimer…
Phase: PHASE2 • Sponsor: Woolcock Institute of Medical Research • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Online sleep therapy may ease anxiety too
Symptom relief Recruiting nowThis study tests whether an online, therapist-guided program for insomnia can also reduce anxiety symptoms. 98 adults with both chronic insomnia and anxiety will either start the program immediately or after a delay. The program includes sleep education, behavioural strategies, a…
Phase: NA • Sponsor: Woolcock Institute of Medical Research • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC